{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:23:53Z","timestamp":1783131833126,"version":"3.54.6"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K03075"],"award-info":[{"award-number":["JP21K03075"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.parkreldis.2026.108336","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:46:15Z","timestamp":1777308375000},"page":"108336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preserved cardiovascular autonomic function predicts the response to initial MAO-B inhibitor treatment in Parkinson's disease"],"prefix":"10.1016","volume":"147","author":[{"given":"Naohito","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnosuke","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Kanemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Oguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetomo","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2026.108336_bib1","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mds.27372","article-title":"Movement disorder society evidence-based medicine committee, international Parkinson and movement disorder society Evidence-based medicine review: update on treatments for the motor symptoms of Parkinson's disease","volume":"33","author":"Fox","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108336_bib2","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(14)60683-8","article-title":"Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial","volume":"384","author":"Gray","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.parkreldis.2026.108336_bib3","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","article-title":"ADAGIO study investigators, A double-blind, delayed-start trial of rasagiline in Parkinson's disease","volume":"361","author":"Olanow","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2026.108336_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fnagi.2017.00321","article-title":"Accumulation of 123I-Ioflupane is a useful marker of the efficacy of selegiline monotherapy in drug-na\u00efve Parkinson's disease","volume":"9","author":"Murakami","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.parkreldis.2026.108336_bib5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2026.108336_bib6","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2026.108336_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2025.1468895","article-title":"Advances in autonomic dysfunction research in Parkinson's disease","volume":"17","author":"Xu","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.parkreldis.2026.108336_bib8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1161\/HYPERTENSIONAHA.118.12642","article-title":"Alpha-synuclein deposition within sympathetic noradrenergic neurons is associated with myocardial noradrenergic deficiency in neurogenic orthostatic hypotension","volume":"73","author":"Isonaka","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.parkreldis.2026.108336_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)11489-J","article-title":"Nigrostriatal dopamine system mediates baroreflex sensitivity in rats","volume":"190","author":"Lu","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.parkreldis.2026.108336_bib10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3233\/JPD-202239","article-title":"Dopaminergic correlates of orthostatic hypotension in de novo Parkinson's disease","volume":"11","author":"Umehara","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2026.108336_bib11","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.2967\/jnumed.118.208686","article-title":"Cardiac sympathetic denervation can predict the wearing-off phenomenon in patients with Parkinson disease","volume":"59","author":"Lee","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.parkreldis.2026.108336_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tins.2016.10.008","article-title":"The threshold theory for Parkinson's disease","volume":"40","author":"Engelender","year":"2017","journal-title":"Trends Neurosci."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380202600163X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380202600163X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:03:58Z","timestamp":1783130638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135380202600163X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":12,"alternative-id":["S135380202600163X"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108336","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preserved cardiovascular autonomic function predicts the response to initial MAO-B inhibitor treatment in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2026.108336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108336"}}